Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

This will play a video. - woman swimming

Transcatheter Aortic Heart Valve Replacement

From a design built on a proven platform¹, the Evolut™ PRO+ system provides the performance and outcomes you need to help patients live life to the fullest.

pdf SMART Trial TAVI (.pdf)

477KB

pdf Discover the advantages of the Evolut™ FX system implant procedure (.pdf)

1.7MB

pdf Download late-breaking clinical evidence: (.pdf)

4 Years outcome from the Evolut™ Low Risk Trial

1.4MB

pdf Download CoreValve™ TAVI Trial 10 Year Data (.pdf)

2.3MB

pdf Evolut™ Low Risk 3 Years Trial (.pdf)

365KB

pdf Echocardiography Guide (.pdf)

1.6MB

Evolut PRO+ system

Built upon the proven Evolut platform, the Evolut PRO+ system offers the lowest delivery profile for 23-29 mm valves, excellent hemodynamics, the broadest annulus range,* and advanced sealing with an external tissue wrap.

See the Evolut PRO+ system

Beauty shot of the Evolut Pro+ system heart valve

Evolut™ first

Download the brochure

Leading Hemodynamics

Designed for large EOAs, low gradients, and minimal patient prosthesis mismatch, the Evolut TAV allows your patient to return to activity faster.^†

See the data

Evolut Pro 29mm

References

Data on file (>20 clinical trials with over 20000 patients enrolled).

Broadest annulus range based on CT derived diameters.

^†

Popma JJ. SURTAVI: Two Year Complete Results from a Randomized Trial of a Self-expanding Transcatheter Heart Valve vs. Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk. Presented at TCT 2018; San Diego, CA.